Donald Trump’s proposed 200% tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
President Donald Trump has consistently demonstrated a preference for maintaining control over escalation rather than allowing events to dictate American strategy.
Is a U.S. president that hits allies with tariff increases, pressures them to spend more on defense, assaults them verbally, and now demands them to join a war, really a trustworthy partner?